Ovatodiolide Suppresses NME1 Ubiquitination and Reactivates Tubular BRAT1–ATM DNA Repair Signaling in Diabetic Kidney Disease

Diabetic kidney disease (DKD) lacks effective therapies that halt disease progression. Although oxidative stress-induced DNA damage in tubular epithelial cells contributes to disease progression, its upstream regulatory mechanisms remain poorly defined. Here, we identify nucleoside diphosphate kinase 1 (NME1) as a key regulator of the DNA damage response (DDR) and a direct target of ovatodiolide (OVA). Proteome-wide and structural analyses reveal that OVA binds NME1 at Lys12 and Arg114 and interferes with its interaction with the E3 ubiquitin ligase TRIM47, thereby suppressing NME1 ubiquitination and proteasomal degradation. Stabilized NME1 interacts with BRAT1 to facilitate assembly of the BRAT1-ATM complex, leading to activation of ATM-dependent DNA repair signaling. Functionally, OVA reduces reactive oxygen species accumulation and DNA damage in tubular epithelial cells through an NME1-dependent mechanism that requires BRAT1-mediated ATM activation. In diabetic mice, OVA ameliorates renal injury independently of glycemic control, whereas tubular NME1 silencing abrogates these effects. Notably, the optimized derivative ACT004 retains NME1-dependent cytoprotective activity with reduced cytotoxicity. Collectively, these findings demonstrate that OVA suppresses TRIM47-mediated NME1 ubiquitination to restore BRAT1-ATM-dependent DNA repair signaling and highlight pharmacological stabilization of NME1 as a potential therapeutic strategy for DKD.

Authors

Institutions

Publication Details

Journal
Advanced Science
Published
2026-11-18
DOI
https://doi.org/10.1002/advs.78884
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ovatodiolide Suppresses NME1 Ubiquitination and Reactivates Tubular BRAT1–ATM DNA Repair Signaling in Diabetic Kidney Disease

Xiaoyang He, Jinzhu Yang, Fenfen Peng, Haibo Long et al.
Advanced Science
Chronic Kidney Disease and Diabetes
article

Ovatodiolide Suppresses NME1 Ubiquitination and Reactivates Tubular BRAT1–ATM DNA Repair Signaling in Diabetic Kidney Disease

Xiaoyang He, Jinzhu Yang, Fenfen Peng, Haibo Long, Danping Tao, Jiaqiong Lin, Xiaowen Chen, Yanxia Liu, Stephen Xia, Yihao Long, Huizhen Wang, Sijia Chen, Yuxian Wang, Liang Wang
article en

Abstract

Diabetic kidney disease (DKD) lacks effective therapies that halt disease progression. Although oxidative stress-induced DNA damage in tubular epithelial cells contributes to disease progression, its upstream regulatory mechanisms remain poorly defined. Here, we identify nucleoside diphosphate kinase 1 (NME1) as a key regulator of the DNA damage response (DDR) and a direct target of ovatodiolide (OVA). Proteome-wide and structural analyses reveal that OVA binds NME1 at Lys12 and Arg114 and interferes with its interaction with the E3 ubiquitin ligase TRIM47, thereby suppressing NME1 ubiquitination and proteasomal degradation. Stabilized NME1 interacts with BRAT1 to facilitate assembly of the BRAT1-ATM complex, leading to activation of ATM-dependent DNA repair signaling. Functionally, OVA reduces reactive oxygen species accumulation and DNA damage in tubular epithelial cells through an NME1-dependent mechanism that requires BRAT1-mediated ATM activation. In diabetic mice, OVA ameliorates renal injury independently of glycemic control, whereas tubular NME1 silencing abrogates these effects. Notably, the optimized derivative ACT004 retains NME1-dependent cytoprotective activity with reduced cytotoxicity. Collectively, these findings demonstrate that OVA suppresses TRIM47-mediated NME1 ubiquitination to restore BRAT1-ATM-dependent DNA repair signaling and highlight pharmacological stabilization of NME1 as a potential therapeutic strategy for DKD.

Advanced Science
Nankai University (CN), The First Hospital of Changsha (CN), Zhujiang Hospital (CN), State Key Laboratory of Medicinal Chemical Biology (CN), Southern Medical University (CN)
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon